ACR: Adalimumab best TNFi for anterior uveitis in ankylosing spondylitis

SAN FRANCISCO – Adalimumab was the clear winner over infliximab and etanercept for anterior uveitis in a Scandinavian database study of 1,365 patients with ankylosing spondylitis.

Office visits for...

Field of Interest: Rheumatology